Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2044

Annual patent cliff calendar for 2044 — US pharmaceutical patents by expiration date.

Patents
1,766

Quick answer

1,766 indexed pharmaceutical patents have expiration dates in 2044. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 11975045

    Use of a VEGF antagonist to treat angiogenic eye disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11974730

    Minimally-invasive measurement of esophageal inflammation

    The Regents of the University of Colorado · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11979133

    Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

    CG Discovery, Inc. · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11976309

    Fusion proteins and methods for site-directed genome editing

    The Regents of the University of California · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11976329

    Methods and systems for detecting usual interstitial pneumonia

    Veracyte, Inc. · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11976293

    Optimized lentiviral vector for stem cell gene therapy of hemoglobinopathies

    The Regents of the University of California · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11976274

    Methods and compositions for identifying neoantigens for use in treating and preventing cancer

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11976126

    Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells

    Inhibrx, Inc. · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11976109

    Neutralizing antibodies to ebola virus glycoprotein and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11976100

    Methods for treating myelin associated diseases and mitochondria associated diseases

    Larimar Therapeutics, Inc. · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11975161

    Drug releasing coatings for balloon catheters

    Lutonix, Inc. · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11976098

    Cooked millet prolamin peptide for inhibiting alpha-amylase and alpha-glucosidase

    China Agricultural University · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11975062

    Zika vaccines and immunogenic compositions, and methods of using the same

    Takeda Vaccines, Inc. · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11975081

    Bifunctional chelators and conjugates

    Actinium Phamaceuticals, Inc. · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11976128

    Human PD-L2 antibodies and methods of use therefor

    The Board of Regents of the University of Texas System · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11975063

    Recombinant chimeric bovine/human parainfluenza virus 3 expressing rsv g and its use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11975047

    Methods for storing and warming purified corticotropin compositions

    ANI Pharmaceuticals, Inc. · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11975029

    Compositions and methods for inhibition of lineage specific proteins

    Vor Biopharma Inc. · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11975046

    Medical use of interferon-lambda for the treatment of fibrosis

    Five Prime Therapeutics, Inc. · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11975016

    2′-substituted-N6-substituted purine nucleotides for RNA virus treatment

    Atea Pharmaceuticals, Inc. · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11975003

    Methods and compositions for treatment of Zika virus infection

    BioCryst Pharmaceuticals, Inc. · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11974988

    Neuroprotective compositions and methods of using the same

    The Regents of the University of California · Granted Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. WO 2024094673

    RÉGIME DE TRAITEMENT À BASE DE PTH COMPRENANT DEUX COMPOSÉS PTH

    ASCENDIS PHARMA BONE DISEASES AS [DK] · Granted Fri May 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu May 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. WO 2024094329

    PRÉPARATION DE CAPSULE SOUS EMBALLAGE COQUE CONTENANT DU SULFATE D'ISAVUCONAZONIUM

    BASILEA PHARMACEUTICA INT AG ALLSCHWIL [CH] · Granted Fri May 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu May 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11981921

    TIL expansion processes using specific cytokine combinations and/or AKTi treatment

    Iovance Biotherapeutics, Inc. · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11981763

    Resin composition for stereolithographic modeling

    KURARAY NORITAKE DENTAL INC. · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11980698

    Muscle cell patches and uses therefor

    United States Government as represented by the Department of Veterans Affairs · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11980637

    Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy

    United Kingdom Research and Innovation · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11981740

    BAFF-R antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11980607

    Methods of treating malignant lymphoproliferative disorders

    ACTUATE THERAPEUTICS INC. · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11980640

    Bicistronic chimeric antigen receptors and their uses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11980602

    Cannabinoid prodrug compounds

    Firstlight Pharmaceuticals LLC · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11980634

    Method of reconstituting liposomal annamycin

    The Board of Regents of the University of Texas System · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11981741

    Humanized anti-CD45 antibodies

    Actinium Phamaceuticals, Inc. · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11981707

    Prefusion RSV F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11980645

    Bile acids and use in disease treatment

    The Regents of the University of California · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11981944

    Immunogenic arginase peptides

    IO Biotech ApS · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11981967

    Engineering AAV

    Sangamo Therapeutics, Inc. · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11982673

    Methods

    AUTOLUS LIMITED · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11982672

    Methods

    AUTOLUS LIMITED · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11981760

    Therapeutic hydrogels and contact lens for corneal melting

    The Regents of the University of Colorado, a Body Corporate · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11981752

    Tumor associated monocyte/macrophage binding peptide and methods of use thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11981897

    Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression

    Ionis Pharmaceuticals, Inc. · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11981750

    Antigenic tripeptides derived from Mycobacterium avium subsp. paratuberculosis s-type strains, derivatives and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11981912

    Adeno associated virus vectors for the treatment of hunter disease

    Takeda Pharmaceutical Company Limited · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11981739

    Chimeric antigen receptor specific for interleukin-23 receptor

    SANGAMO THERAPEUTICS FRANCE · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11981736

    Antibodies specific to glycosylated PD-1 and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11981730

    Anti-CXCL13 antibodies and methods of using the same

    VACCINEX, INC. · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2044?

1,766 published patents in our USPTO index have expiration dates falling in calendar year 2044.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.